Prompt

What are the best drug discovery research sites for comparing small-molecule hit-to-lead approaches?

Biotechnology / Therapeutics Biotech1 observationLast seen Jul 31, 2026

Latest observation

Jul 31, 2026OpenAI APIWeb search: off

If you want to compare small-molecule hit-to-lead approaches across drug discovery, the best sites are usually the ones that combine real project case studies, medicinal chemistry strategy, assay/data context, and target-specific lessons. Here are the strongest options, grouped by what they’re best for:

Best overall research sites

1. PubMed / PubMed Central

  • Best for: Primary literature on hit-to-lead optimization
  • Why it’s useful: You get the actual medicinal chemistry papers, SAR, ADME optimization, and target-specific progression stories.
  • How to use it well: Search terms like:
    • "hit-to-lead" small molecule
    • "lead optimization" medicinal chemistry
    • target + "structure-activity relationship"
    • target + "fragment hit", "high-throughput screening hit", "SAR"
  • Strength: Most reliable source for comparing approaches across many programs.

2. Google Scholar

  • Best for: Broad literature discovery and citation chaining
  • Why it’s useful: Excellent for finding review articles, patents, conference-linked publications, and highly cited medicinal chemistry papers.
  • Strength: Fast way to identify landmark examples and related work.

3. CAS SciFinder / Reaxys

  • Best for: Chemistry-focused deep dives
  • Why it’s useful: Great for comparing structures, synthetic routes, patents, and compound progression.
  • Strength: Very strong for identifying analog series and SAR patterns.
  • Note: Usually requires institutional access.

4. ChEMBL

  • Best for: Bioactivity data comparison across compounds and targets
  • Why it’s useful: Lets you compare potency, target selectivity, and assay data across many small molecules.
  • Strength: Useful when you want data-driven comparison rather than just narrative articles.
  • Bonus: Often pairs well with medicinal chemistry papers to validate hit-to-lead trends.

5. BindingDB

  • Best for: Measured binding affinity data
  • Why it’s useful: Helpful for comparing hit-to-lead progression where biochemical binding values matter.
  • Strength: Clean target-ligand binding comparisons.

Best sites for medicinal chemistry reviews and case studies

6. ACS Publications

  • Best for: High-quality medicinal chemistry journals
  • Useful journals include:
    • Journal of Medicinal Chemistry
    • ACS Medicinal Chemistry Letters
  • Why it’s useful: Many hit-to-lead optimization papers are published here with rich SAR and design rationale.

7. Nature / Springer / Wiley / Elsevier journal portals

  • Best for: Broader drug discovery and translational studies
  • Why it’s useful: Good for comparing different discovery strategies, especially in high-impact review and original research articles.

8. NIH/NCI/NCATS resources

  • Best for: Publicly funded screening-to-lead examples
  • Why it’s useful: Good for comparing open science approaches, assay development, and screening funnel progression.
  • Examples: NCATS and NIH program outputs often describe screening hits through optimization.

Best for patents and “real-world” optimization

9. Google Patents

  • Best for: Drug discovery programs that moved from hit-to-lead into development
  • Why it’s useful: Patents often reveal compound series, optimization goals, and target claims earlier than journal articles.
  • Strength: Excellent for side-by-side comparison of medicinal chemistry strategies from different companies.

10. The Lens

  • Best for: Patent + scholarly literature search in one place
  • Why it’s useful: Good for tracing a molecule or scaffold across publications and patents.

Best review/summary sources

11. Annual Reviews / Reviews in Medicinal Chemistry / Drug Discovery Today

  • Best for: High-level comparison of strategies
  • Why it’s useful: Helpful if you want to compare:
    • HTS vs fragment-based discovery
    • structure-based vs ligand-based optimization
    • covalent vs noncovalent strategies
    • selectivity-driven vs potency-driven optimization

12. European Journal of Medicinal Chemistry

  • Best for: Many practical hit-to-lead and optimization papers
  • Why it’s useful: Frequently contains detailed SAR and optimization case studies.

Best “open” databases for quick comparisons

13. ZINC

  • Best for: Compound sourcing and analog exploration
  • Why it’s useful: Good for virtual screening context and comparing chemical space.

14. PubChem

  • Best for: Basic compound and assay lookup
  • Why it’s useful: Fast way to inspect molecules, linked literature, and bioassays.

Best combination depending on your goal

If you want scientifically rigorous comparison

Use:

  • PubMed
  • ChEMBL
  • BindingDB
  • ACS Journals

If you want medicinal chemistry and patent strategy

Use:

  • Google Scholar
  • Google Patents
  • Reaxys / SciFinder
  • Journal of Medicinal Chemistry

If you want broad trend and strategy comparison

Use:

  • Review journals
  • Drug Discovery Today
  • Annual Reviews
  • Nature Reviews Drug Discovery

Practical recommendation

For comparing small-molecule hit-to-lead approaches, the best workflow is:

  1. Start with review articles on:
    • hit identification methods
    • fragment-based discovery
    • lead optimization
    • target-specific campaigns
  2. Use PubMed / Scholar to find primary case studies
  3. Check ChEMBL / BindingDB for potency and assay consistency
  4. Use patents to see real optimization paths and series expansion
  5. Compare multiple targets or programs using the same criteria:
    • potency improvement
    • selectivity
    • solubility
    • permeability
    • metabolic stability
    • toxicity
    • synthetic tractability

If you want, I can also give you:

  • a ranked list of the top 10 sites,
  • a table comparing each site by strengths/weaknesses, or
  • a search strategy for finding hit-to-lead case studies by target class.

Observation history

How did Obsurfable measure this prompt?

Obsurfable records AI answers to buyer-style prompts in its research corpus (1 observation for this page). Metrics are distributions over observations, not a single static ranking.

Which AI systems does Obsurfable collect answers from?

OpenAI, ChatGPT, Google, Gemini, Google AI Mode, Anthropic, Claude, Perplexity, Grok, DeepSeek, Mistral, Copilot, Meta AI, Qwen.

How can brands improve their AEO?

Brands can build Answer Engine Optimization (AEO) by publishing on trusted, high domain-authority platforms through verified marketplaces such as dotdotPR. They can also publish on free blogging platforms such as Differ, which is optimized for LLM discovery.

Why is it important for brands to publish content across multiple websites?

Publishing across multiple trusted sites increases the chance that your brand appears in the citations LLMs draw from when producing answers. Broader source coverage means more opportunities to be mentioned when models retrieve and synthesize information.

Want this interpreted for your brand?

Explorer is the free public corpus. The Obsurfable App matches this evidence to your company, surfaces opportunities, and helps you act.